Creating Fit-For- Purpose Solutions
We offer to our clients an access to a line of biomarker or cell-based platforms that can be used to dissect the precise action of drugs or monitor patients health. From reviewing existing scientific data, to full study design and optimization, throughout in-depth interpretation and recommendations, GBS is your partner for translational R&D and clinical trials.
Fibrin deposition, lung failure, fibrosis, effects in many tissues and COVID-19: Proposal that excessive inflammasome activation is the basic disease mechanism.
Abstract The activation of the innate immune system during COVID-19 infection, in particular the inflammasome, and the overrepresentation of severe […]
We are thrilled to announce that starting from Oct 2019 our company will participate in PAVE, a challenging project that […]